CN107714873A - 一种中药组合物及用途 - Google Patents
一种中药组合物及用途 Download PDFInfo
- Publication number
- CN107714873A CN107714873A CN201711167194.4A CN201711167194A CN107714873A CN 107714873 A CN107714873 A CN 107714873A CN 201711167194 A CN201711167194 A CN 201711167194A CN 107714873 A CN107714873 A CN 107714873A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine composition
- blood
- leech
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 112
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- 229940079593 drug Drugs 0.000 claims abstract description 42
- 240000004980 Rheum officinale Species 0.000 claims abstract description 25
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 25
- 241001647745 Banksia Species 0.000 claims abstract description 23
- 241000545744 Hirudinea Species 0.000 claims abstract description 23
- 241000220317 Rosa Species 0.000 claims abstract description 23
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 22
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 22
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 22
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 21
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 21
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 21
- 239000004863 Frankincense Substances 0.000 claims abstract description 21
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 21
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 21
- 235000016811 Biondella Nutrition 0.000 claims abstract description 20
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 20
- 241001530209 Swertia Species 0.000 claims abstract description 20
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 19
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 19
- 241000173529 Aconitum napellus Species 0.000 claims abstract description 19
- 241000131329 Carabidae Species 0.000 claims abstract description 19
- 240000004824 Trimezia steyermarkii Species 0.000 claims abstract description 19
- 229940023019 aconite Drugs 0.000 claims abstract description 19
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940116229 borneol Drugs 0.000 claims abstract description 19
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000009136 dragon's blood Substances 0.000 claims abstract description 19
- 244000138993 panchioli Species 0.000 claims abstract description 18
- 239000002023 wood Substances 0.000 claims abstract description 18
- 208000002193 Pain Diseases 0.000 claims description 46
- 230000036407 pain Effects 0.000 claims description 46
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 41
- 206010028980 Neoplasm Diseases 0.000 claims description 37
- 239000008280 blood Substances 0.000 claims description 33
- 210000004369 blood Anatomy 0.000 claims description 32
- 230000000694 effects Effects 0.000 claims description 29
- 230000001737 promoting effect Effects 0.000 claims description 29
- 230000000202 analgesic effect Effects 0.000 claims description 28
- 239000000843 powder Substances 0.000 claims description 28
- 208000035475 disorder Diseases 0.000 claims description 21
- 231100000614 poison Toxicity 0.000 claims description 21
- 230000017531 blood circulation Effects 0.000 claims description 20
- 239000003440 toxic substance Substances 0.000 claims description 14
- 230000004087 circulation Effects 0.000 claims description 10
- 206010036790 Productive cough Diseases 0.000 claims description 6
- 201000007270 liver cancer Diseases 0.000 claims description 6
- 208000014018 liver neoplasm Diseases 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 208000024794 sputum Diseases 0.000 claims description 6
- 210000003802 sputum Anatomy 0.000 claims description 6
- 230000003902 lesion Effects 0.000 claims description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 6
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 201000011510 cancer Diseases 0.000 description 19
- 201000010099 disease Diseases 0.000 description 19
- 210000004185 liver Anatomy 0.000 description 15
- 210000001015 abdomen Anatomy 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 12
- 230000008961 swelling Effects 0.000 description 12
- 238000001035 drying Methods 0.000 description 11
- 208000014674 injury Diseases 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000006820 Arthralgia Diseases 0.000 description 6
- 230000003213 activating effect Effects 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 210000002429 large intestine Anatomy 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- 206010000087 Abdominal pain upper Diseases 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 229940126701 oral medication Drugs 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010010071 Coma Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 241000721047 Danaus plexippus Species 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000007873 sieving Methods 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 210000001685 thyroid gland Anatomy 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 206010058019 Cancer Pain Diseases 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 238000009412 basement excavation Methods 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- -1 poly- Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 241000553739 Aconitum carmichaelii var. truppelianum Species 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010013082 Discomfort Diseases 0.000 description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000246500 Gentianella aspera Species 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 2
- 241001582888 Lobus Species 0.000 description 2
- 208000008771 Lymphadenopathy Diseases 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000008350 Pruritus Vulvae Diseases 0.000 description 2
- 241000399256 Pteromyini Species 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 240000006688 Telosma cordata Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000024770 Thyroid neoplasm Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 2
- 208000011279 abdominal lump Diseases 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000035508 accumulation Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000022532 enlargement of lymph nodes Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 201000002313 intestinal cancer Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 210000003739 neck Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 231100000925 very toxic Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 241000169680 Aphloia theiformis Species 0.000 description 1
- 241000271309 Aquilaria crassna Species 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241001415440 Bufo gargarizans Species 0.000 description 1
- 241000269420 Bufonidae Species 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 244000262912 Desmodium triflorum Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 240000005717 Dioscorea alata Species 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241001415432 Duttaphrynus melanostictus Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241001489980 Eupolyphaga sinensis Species 0.000 description 1
- 239000001293 FEMA 3089 Substances 0.000 description 1
- 208000002513 Flank pain Diseases 0.000 description 1
- 241000576429 Forsythia suspensa Species 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 241001293752 Gentiana manshurica Species 0.000 description 1
- 241000486199 Gentiana rigescens Species 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 241000237678 Hirudinidae Species 0.000 description 1
- 241000237903 Hirudo Species 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 208000032912 Local swelling Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000007433 Lymphatic Metastasis Diseases 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 208000002454 Nasopharyngeal Carcinoma Diseases 0.000 description 1
- 206010061306 Nasopharyngeal cancer Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 244000021150 Orbignya martiana Species 0.000 description 1
- 235000014643 Orbignya martiana Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 241000864228 Polyphaga plancyi Species 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000555746 Pteromys volans Species 0.000 description 1
- 235000008090 Rheum palmatum Nutrition 0.000 description 1
- 240000001745 Rheum palmatum Species 0.000 description 1
- 241000124033 Salix Species 0.000 description 1
- 244000272264 Saussurea lappa Species 0.000 description 1
- 235000006784 Saussurea lappa Nutrition 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 206010040830 Skin discomfort Diseases 0.000 description 1
- 244000197975 Solidago virgaurea Species 0.000 description 1
- 235000000914 Solidago virgaurea Nutrition 0.000 description 1
- 208000005250 Spontaneous Fractures Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 235000017352 Telosma cordata Nutrition 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 1
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 1
- 241000301399 Trogopterus xanthipes Species 0.000 description 1
- 241000964941 Whitmania Species 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000146 antalgic effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 201000001531 bladder carcinoma Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- BFPSDSIWYFKGBC-UHFFFAOYSA-N chlorotrianisene Chemical compound C1=CC(OC)=CC=C1C(Cl)=C(C=1C=CC(OC)=CC=1)C1=CC=C(OC)C=C1 BFPSDSIWYFKGBC-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- QTCANKDTWWSCMR-UHFFFAOYSA-N costic aldehyde Natural products C1CCC(=C)C2CC(C(=C)C=O)CCC21C QTCANKDTWWSCMR-UHFFFAOYSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- DGABKXLVXPYZII-SIBKNCMHSA-N hyodeoxycholic acid Chemical compound C([C@H]1[C@@H](O)C2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 DGABKXLVXPYZII-SIBKNCMHSA-N 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- ISTFUJWTQAMRGA-UHFFFAOYSA-N iso-beta-costal Natural products C1C(C(=C)C=O)CCC2(C)CCCC(C)=C21 ISTFUJWTQAMRGA-UHFFFAOYSA-N 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000010446 mirabilite Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 238000011248 postoperative chemotherapy Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000007674 radiofrequency ablation Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000009286 sanguis draxonis Substances 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 208000013076 thyroid tumor Diseases 0.000 description 1
- 231100000730 tolerability Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 208000010570 urinary bladder carcinoma Diseases 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/24—Mucus; Mucous glands; Bursa; Synovial fluid; Arthral fluid; Excreta; Spinal fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/65—Amphibians, e.g. toads, frogs, salamanders or newts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/285—Aucklandia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Insects & Arthropods (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种中药组合物,该中药组合物的原料药包括以下按重量份计的成份,乳香15~30份、没药15~30份、桃仁15~30份、血竭10~20份、水蛭10~15份、地鳖虫10~15份、五灵脂15~30份、大黄15~30份、制川乌8~15份、制草乌8~15份、木香15~30份、降香10~15份、龙胆草15~30份、苦参15~30份、人工牛黄3~9份、干蟾皮8~15份、芒硝15~30份、冰片6~12份。本发明的中药组合物是在辨证基础上采用的复方配伍,在消瘤的同时,也对机体进一步进行整体调节,有利于提高患者的生活质量。
Description
技术领域
本发明涉及中药领域,特别是涉及一种中药组合物及用途。
背景技术
据统计,2012年全球共有癌症病例约3255万人,其中新发病例约1410万人,死亡病例约820万人,57%的癌症患者以及65%的癌症死亡患者来自于发展中国家。当前,我国的癌症防治工作已经成为一个主要的公共卫生问题。近年来,我国的癌症临床发病率和死亡率一直在逐年上升,从2010年开始已经成为我国临床患者主要的致死原因,成为社会及公共医疗支出的沉重负担。据统计,2015年我国癌症新发病例约429万人,死亡病例约281万人,病例以肺癌、乳腺癌、食管癌、胃癌、肠癌、胰腺癌、肝癌、卵巢癌等实体肿瘤为主。其中,肺癌、胃癌、肝癌、食道癌四种癌症就占到了我国癌症发病率的57%。鼻咽癌、甲状腺癌、乳腺癌、肝癌、胰腺癌、肠癌、肾癌、膀胱癌、卵巢癌、宫颈癌等实体肿瘤,随着疾病进展,除表现为局部肿块及结节,还会因为复发及转移等原因,出现皮下、胸腔及腹腔肿块,局部黏连、水肿,淋巴结肿大。肿瘤除破坏局部组织器官结构,侵及神经、血管、骨膜,压迫或病理性骨折,分泌细胞介素、肿瘤坏死因子等引起疼痛外,还会导致局部的组织坏死、感染、皮肤破溃、伤口难以愈合等严重病理变化。
对于这部分患者,西医目前多采用放疗、射频消融、伽马刀等方法进行局部治疗,具有一定的临床疗效。然而,上述疗法不仅费用昂贵,造成社会及家庭的沉重负担,还受到病灶大小、数量、所处位置以及患者体质状况等诸多因素的限制,难以广泛应用于临床;而且,上述疗法还会产生骨髓抑制、放射性炎症、皮疹、溃疡、口干、厌食、恶心、呕吐、腹泻、腹痛、疲乏、感染等一系列严重的副作用,导致很大一部分患者均难以承受。目前WHO大力推广的控制癌痛方案“三阶梯药物止痛法”,止痛效果虽然比较确切,但长期应用镇痛剂毒副作用较大,依赖性强,并因为受到不同患者耐受性的限制,致使部分患者临床止痛效果欠佳。
中医学对本病的认识较早,在公元前16世纪至11世纪殷墟出土的甲骨文中己有“瘤”这一文字。成书于战国秦汉时期的中医经典著作《黄帝内经》中记载的“肠蕈”、“石瘿”、“乳岩”、“筋瘤”、“失荣”、“癥瘕”、“肠瘤”等疾病,其临床表现均与目前一些常见的恶性肿瘤症状相似。东晋·葛洪《肘后备急方》载有“腹中有物如石,痛如刺,昼夜啼呼,不治之,百日死”,说明当时的医学家已经认识到了恶性肿瘤会引起剧烈疼痛。在中医古籍记载中,宋代·东轩居士所著的《卫济宝书》中就已经第一次有了“癌疾”这一疾病名称;在明代时期的医学论著中,已经开始用“癌”字来统称恶性肿瘤类疾病。此后,历代医家对此类疾病也有了更加系统的论述。可见,中医学对此类疾病早有充分认识,其阐述的发病机理与治疗经验也为后世治疗打下了良好的基础。
经过对现有技术的检索发现:
中国专利文献号CN104161952A,公开日2014.11.26,公开了一种治疗甲状腺肿瘤的中药组合物,包括外敷药和内服药。内服药由以下各原料药制成:柴胡10-18份,炒白术7-15份,陈皮11-19份,川芎8-15份,制半夏4-13份,连翘5-14份,土贝母5-15份,甘草2-9份,青皮5-11份,海蛤壳7-20份,当归5-13份,络石藤13-19份,黄药子4-10份,一枝黄花5-12份; 外敷药由海螵蛸、忍冬藤组成。该技术适用于甲状腺及淋巴腺肿瘤,效果较好。该技术临床治疗范围较局限,且需药物口服及外敷同时进行,用法复杂,临床应用不便。
中国专利文献号CN106389742A,公开日2017.02.05,公开了一种治疗癌性疼痛的中药组合物,由以下各原料药制成:槟榔10~20份、沉香10~15份、降香10~15份、厚朴10~20份、三七10~20份、桂枝15~20份。该技术适用于癌性疼痛,并可改善患者恶心、呕吐、腹胀、便秘等不适,效果较好。但该技术组方有6味中药,药量10~20g,或许可改善癌症患者的早期临床症状,但是难以针对恶性肿瘤“癥、瘕、积、聚、毒”的特性,以及临床病情反复缠绵、逐渐加重、日久难愈的复杂性及难治性进行有效治疗。
发明内容
为解决现有技术临床治疗范围较局限,用法复杂,临床应用不便,且不能进行有效治疗技术问题,本发明采用的一个技术方案是,提供一种中药组合物,该中药组合物的原料药包括以下按重量份计的成份,乳香15~30份、没药15~30 份、桃仁15~30份、血竭10~20份、水蛭10~15份、地鳖虫10~15份、五灵脂15~30份、大黄15~30份、制川乌8~15份、制草乌8~15份、木香15~30份、降香10~15份、 龙胆草15~30份、苦参15~30份、人工牛黄3~9份、干蟾皮8~15份、芒硝15~30份、冰片6~12 份。
本发明的一个实施例中,所述中药组合物成份按重量份计为,乳香25份、没药25份、桃仁20份、血竭15份、水蛭10份、地鳖虫10份、五灵脂15份、大黄15份、制川乌15份、制草乌15份、木香30份、降香15份、龙胆草15份、苦参15份、人工牛黄3份、干蟾皮8份、芒硝15份、冰片12 份。
本发明上述实施例中以制川乌、制草乌温经、通络、止痛,为君药;木香、降香行气止痛,乳香、没药、桃仁、血竭活血定痛,水蛭、地鳖虫、五灵脂、大黄逐瘀消瘕,共为臣药;龙胆草、苦参清热燥湿,人工牛黄、干蟾皮、芒硝解毒消肿,共为佐药;冰片辛散,可引诸药直达病灶,兼可止痛,为使药。全方配伍以通络止痛为主,辅以行气、活血、消癥、止痛、燥湿、解毒,共奏消瘤止痛之功。
本发明的另一个实施例,所述中药组合物成份按重量份计为,乳香30份、没药30份、桃仁30份、血竭20份、水蛭15份、地鳖虫15份、五灵脂30份、大黄20份、制川乌8份、制草乌8份、木香20份、降香10份、 龙胆草15份、苦参15份、人工牛黄3份、干蟾皮8份、芒硝15份、冰片6份。
本发明的另一个实施例中以水蛭、地鳖虫破血逐瘀消癥,为君药;五灵脂、大黄活血化瘀,乳香、没药、桃仁、血竭散瘀定痛,制川乌、制草乌、木香、降香理气止痛,共为臣药;龙胆草、苦参清热燥湿,人工牛黄、干蟾皮、芒硝解毒消肿,共为佐药;冰片辛散,可引诸药直达病灶,兼可止痛,为使药。全方配伍以逐瘀消癥为主,辅以理气、活血、止痛、消肿、燥湿、解毒,共奏消瘤止痛之功。
本发明的又一个实施例中,所述中药组合物成份按重量份计为,乳香15份、没药15份、桃仁15份、血竭10份、水蛭10份、地鳖虫10份、五灵脂15份、大黄30份、制川乌8份、制草乌8份、木香20份、降香10份、龙胆草30份、苦参30份、人工牛黄6份、干蟾皮10份、芒硝20份、冰片9份。
本发明的又一个实施例中本方以龙胆草、苦参清热解毒、燥湿消肿,为君药;大黄逐瘀利湿,人工牛黄、干蟾皮、芒硝化痰消肿,木香、降香行气燥湿,乳香、没药、水蛭、地鳖虫、五灵脂活血消癥,共为臣药;制川乌、制草乌、桃仁、血竭温经活血止痛,共为佐药;冰片辛散,可引诸药直达病灶,兼可止痛,为使药。全方配伍以燥湿解毒为主,辅以理气、化痰、活血、止痛、清热、解毒,共奏消瘤止痛之功。
本发明的再一个实施例中,所述成份按重量份计为,乳香15份、没药15份、桃仁15份、血竭10份、水蛭10份、地鳖虫10份、五灵脂15份、大黄30份、制川乌8份、制草乌8份、木香15份、降香10份、 龙胆草20份、苦参20份、人工牛黄9份、干蟾皮15份、芒硝30份、冰片12 份。
本发明的再一个实施例中,以大黄、人工牛黄清热解毒,为君药;干蟾皮、芒硝解毒消肿,龙胆草、苦参清热燥湿,木香、降香行气止痛,乳香、没药、水蛭、地鳖虫、五灵脂活血消癥,共为臣药;制川乌、制草乌、桃仁、血竭温经活血止痛,共为佐药;冰片辛散,可引诸药直达病灶,兼可清热止痛,为使药。全方配伍以清热解毒为主,辅以燥湿、理气、止痛、活血、散瘀、消癥,共奏消瘤止痛之功。
本发明提供了一种中药组合物的用途,将所述的中药组合物用于治疗实体肿瘤。
进一步,所述肿瘤选自卵巢癌或肝癌。
进一步,所述中药组合物具有至少以下一种功效:
a.通络止痛、行气、活血、消癥、止痛、燥湿、解毒;
b.逐瘀消癥、理气、活血、止痛、消肿、燥湿、解毒;
c.燥湿解毒、理气、化痰、活血、止痛、清热、解毒;
d.清热解毒、燥湿、理气、止痛、活血、散瘀、消癥。
进一步,将所述中药组合物药粉放入透气外敷袋中,置于患处对应皮肤,所述药粉中心位置与病灶中心位置吻合,每天外敷10~12小时。
申请人考察了多种给药方式,包括传统的汤剂、丸剂、酒剂、散剂等。根据临床疗效,最终选择散剂以及外敷疗法。中药外敷疗法属中医特色疗法之一,其历史悠久,临床应用经验丰富。早在春秋战国时期的帛书《五十二病方》中就有肚脐填药、敷药、涂药及灸脐法的记载。而后,历代医家典籍多有记载应用中药外敷治疗内外科疾病的治则、用药及医案。如唐代·孙思邀在《千金方》中记载可用中药“癌痛散”外敷治疗乳岩;明代·陈实功在《外科正宗》中记载用“阿魏化坚膏”外敷治疗颈部瘰疬。正如清代·吴师机所著的《理瀹骈文》中认为:“外治之理,即内治之理,外治之药,亦即内治之药,所异者,法耳”。
可见,中药外敷疗法的临床应用十分广泛,经过历代医家不断地进行经验总结,已经形成了一套系统的理论、治则、遣方、用药体系。中药外敷疗法既可使药物直接作用于皮肤,透达于腠理,药效直达病灶,疏通经脉,调和气血,发挥局部直接治疗作用;还可以避免口服药物的消化道灭活作用,以及口服药物所带来的不良反应。中药外敷疗法既可有效抑制肿瘤的局部蔓延及无序生长,还可明显缓解疼痛,改善临床症状,具有极大的临床应用优势。
本方法具有操作简单、经济实用、疗效显著、副作用少等特点,适合临床推广应用,尤其适用于罹患恶性实体肿瘤,局部肿块或淋巴结肿大明显,而又食欲较差,难以口服用药的患者,可明显提高患者的依从性,改善临床症状。特别是一些恶性肿瘤晚期患者,因其正气已虚,不耐攻伐,脾胃吸收功能较弱,单靠口服药物治疗效果欠佳,而本申请所采用的中药外敷法则更具优势,药物直接敷于患处,透皮吸收,生物利用度较高。
经上述工艺制得的消瘤方,外敷可有效治疗各种实体肿瘤及淋巴结转移肿大,还可以改善患者局部疼痛、肿胀等不适,避免皮肤出现破损、溃烂,提高患者生活质量,延缓疾病进展。中药粉剂的剂型分散度高,生物利用度高,制备简单,易控制剂量,能保证药物的临床疗效。相较传统中西药治疗,本发明有效率高、耐药性低、毒副作用及并发症少,相对价格便宜。对于癌痛患者,不失为一种可供选择的有效治疗手段。
乳香:橄榄科植物乳香树BoswelliacarteriiBirdw.及同属植物Boswelliabhaw-dajianaBirdw.树皮渗出的树脂。春、夏采收,捣成粉末,于锅内炒溶,倒出待微冷后,切成小块。味辛、苦;性温;归心、肝、脾经。具有活血定痛,消肿生肌的功效。主治胸痹心痛,胃脘疼痛,痛经经闭,产后瘀阻,癥瘕腹痛,风湿痹痛,筋脉拘挛,跌打损伤,痈肿疮疡。
没药:橄榄科植物地丁树CommiphoramyrrhaEngl.或哈地丁树CommiphoramolmolEngl.的干燥树脂。夏、冬季采收,捣碎,炒至焦黑色,稍冷,捣成小块。味辛、苦;性平;归心、肝、脾经。具有散瘀定痛,消肿生肌的功效。主治胸痹心痛,胃脘疼痛,痛经经闭,产后瘀阻,癥瘕腹痛,风湿痹痛,跌打损伤,痈肿疮疡。
桃仁:蔷薇科植物桃Prunuspersica(L.)Batsch或山桃Prusuadavidiana (Carr.)Fr anch.的干燥成熟种子。果实成熟后采收,取出种子,晒干。味苦、甘;性平;归心、肝、大肠经。具有活血祛瘀,润肠通便,止咳平喘的功效。主治经闭,痛经,癥瘕痞块,肺痈,肠痈,跌扑损伤,肠燥便秘,咳嗽气喘。
血竭:棕榈科植物麒麟竭DaemonoropsdracoB1.果实渗出的树脂。除去杂质,打成碎粒或研成细末。味甘、咸;性平;归心、肝经。具有活血定痛,化瘀止血,生肌敛疮的功效。主治跌打损伤,心腹瘀痛,外伤出血,疮疡不敛。
水蛭:水蛭科动物蚂蟥WhitmaniapigraWhitman、水蛭Hirudonippponicawhitman或柳叶蚂蟥WhitmaniaacranulataWhitman的干燥全体。夏、秋二季捕捉,沸水烫死,干燥。味咸、苦;性平;有小毒;归肝经。具有破血通经,逐瘀消癥的功效。主治血瘀经闭,癥瘕痞块,中风偏瘫,跌扑损伤。
土鳖虫:鳖蠊科昆虫地鳖EupolyphagaSinesisWalker或冀地鳖Steleophagaplancyi(Boleny)的雌虫干燥体。捕捉后,沸水烫死,晒干或烘干。味咸;性寒;有小毒;归肝经。具有破血逐瘀,续筋接骨的功效。主治跌打损伤,筋伤骨折,血瘀经闭,产后瘀阻腹痛,癥瘕痞块。
五灵脂:鼯鼠科动物橙足鼯鼠Trogopterus Xanthipes Milne-Edwards或飞鼠科动物小飞鼠Pteromys volans L.的干燥粪便。全年可收采,除净砂石、泥土等杂质。味甘;性温;归肝、脾经。具有活血止痛,化瘀止血,消积解毒的功效。主治心腹瘀血作痛,痛经,血瘀经闭,产后瘀血腹痛,崩漏下血,跌打损伤,蛇、虫咬伤。
大黄:蓼科植物掌叶大黄RheumpalmatumL.或唐古特大黄Rheumtanguticum.Maxim.exBalf.或药用大黄RheumoffcihaleBaill.的干燥根和茎。秋末或次春发芽前采挖,除去细根,刮去外皮,干燥。其味苦;性寒;归脾、胃、大肠、肝、心包经;具有泻下攻积,清热泻火,凉血解毒,逐瘀通经,利湿退黄的功效。主治实热积滞便秘,血热吐衄,目赤咽肿,痈肿疔疮,肠痈腹痛,瘀血经闭,产后瘀阻,跌打损伤,湿热痢疾,黄疸尿赤,淋证,水肿。
制川乌:毛茛科植物乌头AconitumcarmichaeliiDebx.的干燥母根。6月下旬至8月上旬采挖,除去子根、须根及泥沙,水浸至内无干心,加水煮至取大个切开内无白心,口尝微有麻舌感,取出,晾至六成干,切片,干燥。味辛、苦;性热;有大毒;归心、肝、肾、脾经。具有祛风除湿,温经止痛的功效。主治风寒湿痹,关节疼痛,心腹冷痛,寒疝作痛。
制草乌:毛茛科植物北乌头AconitumkusnezoffiiReichb.的干燥块根。秋季采挖,除去须根和泥沙,水浸至内无干心,加水煮至取大个切开内无白心,口尝微有麻舌感,取出,晾至六成干,切片,干燥。味辛、苦;性热;有大毒;归心、肝、肾、脾经。具有祛风除湿,温经止痛的功效。主治风寒湿痹,关节疼痛,心腹冷痛,寒疝作痛。
木香:菊科植物木香Aucklandia lappa Decne. 的干燥根。秋、冬二季采挖,除去泥沙和须根,切段,干燥后撞去粗皮。味辛、苦;性温;归脾、胃、大肠、三焦、胆经。具有行气止痛,健脾消食的功效。主治胸胁、脘腹胀痛,泻痢后重,食积不消,不思饮食。
降香:豆科植物降香檀DalbergiaodoriferaT.Chen树干和根的干燥心材。全年均可采收,除去边材,阴干。味辛;性温;归肝、脾经。具有化瘀止血,理气止痛的功效。主治吐血,衄血,外伤出血,肝郁胁痛,胸痹刺痛,跌扑伤痛,呕吐,腹痛。
龙胆草:龙胆科植物条叶龙胆GentianamanshuricaKitag.或龙胆GentianaBge.或三花龙胆GentianatrifloraPalL或滇龙胆GentianarigescensFranch.的干燥根和根茎。春、秋二季采挖,洗净,干燥。味苦;性寒;归肝、胆经。具有清热燥湿,泻肝胆火的功效。主治湿热黄疸,阴肿阴痒,带下,湿疹瘙痒,肝火目赤,耳呜耳聋,胁痛,口苦,强中,惊风抽搐。
苦参:豆科植物苦参SophoraflavescensAit.的干燥根。春、秋二季采挖,除去根头和小支根,大小分开,洗净,浸泡至约六成透时,润透,切厚片,干燥。味苦;性寒;归心、肝、胃、大肠、膀胱经。具有清热燥湿,杀虫,利尿的功效。主治热痢,便血,黄疸,尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风,外用治滴虫性阴道炎。
人工牛黄:牛胆粉、胆酸、猪去氧胆酸、牛磺酸、胆红素、胆固醇、微量元素等加工制成。味甘;性凉;归心、肝经。具有清热解毒,化痰定惊的功效。主治痰热谵狂,神昏不语,小儿急惊风,咽喉肿痛,口舌生疮,痈肿疔疮。
干蟾皮:蟾蜍科动物中华大蟾蜍BufobufogargarizansCantor或黑眶蟾蜍BufomelanostictusSchneider的皮。夏、秋季捕捉,除去骨脏,将体腔撑开晒干。味辛;性凉;微毒;归心、肺、脾、大肠经。具有清热解毒,利水消胀的功效。主治痈疽,肿毒,瘰疬,肿瘤,疳积腹胀,慢性气管炎。
芒硝:硫酸盐类矿物皮硝经加工精制而成的结晶体。味咸、苦;性寒;归胃、大肠经。具有泻下通便,润燥软坚,清火消肿的功效。主治实热积滞,腹满胀痛,大便燥结,肠痈肿痛,乳痈,痔疮肿痛。
冰片:松节油、樟脑等为原料经化学方法合成。味辛、苦;性微寒;归心、脾、肺经。具有开窍醒神,清热止痛的功效。主治热病神昏,惊厥,中风痰厥,气郁暴厥,中恶昏迷,胸痹心痛,目赤,口疮,咽喉肿痛,耳道流脓。
传统中医学认为,本病成因多是由于外感六淫、服药不当、有害物质侵袭、先天不足、饮食失宜、情志不遂、劳逸失度等多种原因导致人体脏腑功能失调、气血运行不畅,气滞、血瘀、痰湿胶着,聚而成瘤。癌瘤既是人体各种机能失调的病理产物,又留滞体内,成为阻碍气血、津液正常运化的新的致病因素,由此形成恶性循环,导致病情缠绵,不断耗伤机体正气,终至不愈。中医对于本病的临床治疗,既需要掌握整体病机,又要具体辨别病患的不同状态,有所侧重。临床治疗多在辨证论治的指导下,根据患者不同的临床证候,采用理气、活血、化瘀、消癥、祛湿、化痰、扶正、解毒等法则组方治疗。
申请人根据病例的实际情况进行辨证加减。如局部疼痛较重,则以通络止痛为主,辅以活血消癥、燥湿解毒,共奏消瘤止痛之功,具体应用实施例1所制的消瘤1号方;如癥瘕血瘀较重,则以逐瘀消癥为主,辅以理气止痛、消肿解毒,共奏破瘀消瘤之功,具体应用实施例2所制的消瘤2号方;如湿热肿胀较重,则以清热燥湿为主,辅以理气活血、消肿解毒,共奏祛瘤消肿之功,具体应用实施例3所制的消瘤3号方;如局部热毒较重,则以清热解毒为主,辅以理气燥湿、活血消癥,共奏解毒消瘤之功。具体应用实施例4所制的消瘤4号方。
本发明的中药组合物是在辨证基础上采用的复方配伍,在消瘤的同时,也对机体进一步进行整体调节,有利于提高患者的生活质量。
具体实施方式
实施例1
一种治疗实体肿瘤的外用中药组合物,由以下组分制作而成:乳香25g、没药25 g、桃仁20g、血竭15g、水蛭10g、地鳖虫10g、五灵脂15g、大黄15g、制川乌15g、制草乌15g、木香30g、降香15g、龙胆草15g、苦参15g、人工牛黄3g、干蟾皮8g、芒硝15g、冰片12 g。
具体制备方法:
(1)前处理:将上述药物分别洗净,然后烘制;
(2)粉碎:将步骤(1)中烘制后的所述药物进行粉碎,形成药粉;
(3)过筛:用筛网将上述药粉进行过筛,得到药物细粉;
(4)混合:将所述药物细粉进行混合,混合均匀后,加入适当辅料制得成品。
进一步地,步骤(1)中所述烘制均采用DHG-9145A型电热恒温鼓风干燥箱进行烘干;所述烘制的温度为60~80℃;所述烘制时,所述的烘制温度先高后低,每1小时调温一次。
进一步地,步骤(2)中所述粉碎均采用DFY-500型打粉机进行打粉;所述粉碎的环境温度为22℃,所述粉碎的环境相对湿度为55%。
进一步地,步骤(3)中所述过筛为采用60目的筛网进行过滤3次。过第一次筛后,得到过筛后的第一次细粉和筛上的第一次粗粉;将所述第一次粗粉进行粉碎后,再过第二次筛,得到第二次细粉和筛上的第二次粗粉;将所述第二次粗粉进行粉碎后,再过第三次筛,得到第三次细粉和筛上的第三次粗粉;将第三次粗粉弃去,最后将第一次细粉、第二次细粉和第三次细粉混合均匀后得到待混合的所述细粉。
实施例 2
一种治疗实体肿瘤的外用中药组合物,由以下组分制作而成:乳香30g、没药30 g、桃仁30g、血竭20g、水蛭15g、地鳖虫15g、五灵脂30g、大黄20g、制川乌8g、制草乌8g、木香20g、降香10g、 龙胆草15g、苦参15g、人工牛黄3g、干蟾皮8g、芒硝15g、冰片6g。
具体制备方法,同实施例1。
实施例 3
一种治疗实体肿瘤的外用中药组合物,由以下组分制作而成:乳香15g、没药15 g、桃仁15g、血竭10g、水蛭10g、地鳖虫10g、五灵脂15g、大黄30g、制川乌8g、制草乌8g、木香20g、降香10g、 龙胆草30g、苦参30g、人工牛黄6g、干蟾皮10g、芒硝20g、冰片9g。
具体制备方法,同实施例1。
实施例 4
一种治疗实体肿瘤的外用中药组合物,由以下组分制作而成:乳香15g、没药15g、桃仁15g、血竭10g、水蛭10g、地鳖虫10g、五灵脂15g、大黄30g、制川乌8g、制草乌8g、木香15g、降香10g、 龙胆草20g、苦参20g、人工牛黄9g、干蟾皮15g、芒硝30g、冰片12 g。
具体制备方法,同实施例1。
当然,除了粉碎后外敷外,还可以将中药提取后制备成外用制剂,如软膏、贴剂、洗剂、搽剂等。本发明中药组合物中可以适量含有乙醇,有助于成分渗出。另外,为了提高透皮吸收,亦可以加入促渗剂,促进药物成分更多地进入体内。
本发明用法:外用,将药粉直接放入纱布外敷袋中,药粉摊开,面积尽量大一些,将布袋置于患处对应皮肤,药粉中心位置与病灶中心位置基本吻合;如无明显不适,可每日连续外敷于患处10-12小时;如出现局部皮肤不适,可在外敷3-4小时后取下药包,休息30-60分钟后继续外敷,间隔时间可根据自身情况进行调节。若使用药粉外敷时,可外加热源,刺激药物分子运动,更便于起效;或者也可以浸泡热水后再外敷。
实施例5
病例1:患者谢某,女,34岁。2017年1月于当地医院体检查彩超示:甲状腺右侧叶小结节(5mm*3mm),建议穿刺检查。患者因惧怕有创检查,遂至我处寻求中医药治疗。就诊时患者一般情况良好,无明显不适,经辨证后予消瘤3号方外敷治疗。2周后患者复查彩超示:甲状腺右侧叶小结节(3mm*2mm),继续予消瘤3号方外敷治疗;4周后患者复查彩超示甲状腺双侧叶未见明显异常,继予消瘤3号方外敷巩固治疗2周。后患者病情平稳,定期复查甲状腺彩超均未见明显异常。
病例2:杨某,女,45岁。2016年5月因“卵巢癌”于当地医院行手术治疗,术后化疗4疗程。2017年2月患者因自觉腹部胀痛,复查腹部CT示:卵巢MT 术后;腹膜转移;腹膜后淋巴结肿大;腹水。患者因惧怕化疗引起的剧烈副反应,遂于2017年3月至我处寻求中医药治疗。就诊时患者精神尚可,腹部轻压痛,未及明显肿块,移动性浊音(+-),经辨证后予消瘤2号方外敷治疗。1周后患者自觉腹痛减轻,精神状态较前好转;2周后患者腹痛明显好转,已无明显不适。后患者一直坚持应用消瘤方外敷治疗,病情平稳。
病例3:患者李某,男性,46岁。2015年4月因右胁部皮下肿块逐渐增大至当地医院就诊,确诊为“肝癌伴多发转移”,患者于当地医院行TACE术治疗2次,病情未见明显好转,遂于2015年7月至我处就诊。就诊时患者精神较差,右胁部胀痛,巩膜及皮肤明显黄染,右肋缘下可见突出肿块,直径约5cm,质硬,皮肤灼热。经辨证后予消瘤4号方外敷,并配合中药汤剂口服治疗。10日后患者右胁疼痛较前减轻,肿块略有缩小;后一直予消瘤4号方、消瘤1号方、消瘤2号方交替外敷,患者病情一度较平稳,但患者终因全身多处转移,消化道出血于2016年5月临床死亡。但直到患者临终阶段,其右肋下肿块未出现局部皮肤破溃及剧烈疼痛,肿块直径约缩小至3cm。
本发明水蛭、地鳖虫、五灵脂、大黄破血通经、逐瘀消癥,大黄兼能清热泻火、利湿解毒;乳香、没药、桃仁、血竭散瘀定痛、消肿生肌;制川乌、制草乌温经、祛湿、止痛,木香、降香行气止痛,木香兼可健脾消积;龙胆草、苦参清热、燥湿、消肿,人工牛黄、干蟾皮、芒硝清热解毒、软坚消肿,冰片清热止痛,更可引诸药直达病灶。诸药配伍,共奏活血消癥、温经通络、理气止痛、燥湿消肿、清热解毒之功效。本发明在临床应用过程中,除可控制癌肿生长,达到消瘤的效果,还可以明显改善疼痛、局部肿胀等症状,提高患者生活质量,延缓疾病进展。
以上所述仅为本发明的实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书内容所作的等效结构或等效流程变换,或直接或间接运用在其他相关的技术领域,均同理包括在本发明的专利保护范围内。
Claims (10)
1.一种中药组合物,其特征在于,该中药组合物的原料药包括以下按重量份计的成份,乳香15~30份、没药15~30 份、桃仁15~30份、血竭10~20份、水蛭10~15份、地鳖虫10~15份、五灵脂15~30份、大黄15~30份、制川乌8~15份、制草乌8~15份、木香15~30份、降香10~15份、 龙胆草15~30份、苦参15~30份、人工牛黄3~9份、干蟾皮8~15份、芒硝15~30份、冰片6~12 份。
2.根据权利要求1所述的一种中药组合物,其特征在于,所述成份按重量份计为,乳香25份、没药25 份、桃仁20份、血竭15份、水蛭10份、地鳖虫10份、五灵脂15份、大黄15份、制川乌15份、制草乌15份、木香30份、降香15份、龙胆草15份、苦参15份、人工牛黄3份、干蟾皮8份、芒硝15份、冰片12 份。
3.根据权利要求1所述的一种中药组合物,其特征在于,所述成份按重量份计为,乳香30份、没药30 份、桃仁30份、血竭20份、水蛭15份、地鳖虫15份、五灵脂30份、大黄20份、制川乌8份、制草乌8份、木香20份、降香10份、 龙胆草15份、苦参15份、人工牛黄3份、干蟾皮8份、芒硝15份、冰片6份。
4.根据权利要求1所述的一种中药组合物,其特征在于,所述成份按重量份计为,乳香15份、没药15 份、桃仁15份、血竭10份、水蛭10份、地鳖虫10份、五灵脂15份、大黄30份、制川乌8份、制草乌8份、木香20份、降香10份、龙胆草30份、苦参30份、人工牛黄6份、干蟾皮10份、芒硝20份、冰片9份。
5.根据权利要求1所述的一种中药组合物,其特征在于,所述成份按重量份计为,乳香15份、没药15份、桃仁15份、血竭10份、水蛭10份、地鳖虫10份、五灵脂15份、大黄30份、制川乌8份、制草乌8份、木香15份、降香10份、 龙胆草20份、苦参20份、人工牛黄9份、干蟾皮15份、芒硝30份、冰片12 份。
6.根据权利要求1所述的一种中药组合物,其特征在于,所述中药组合物为外用制剂。
7.一种中药组合物的用途,其特征在于,将权利要求1~6任一项所述中药组合物用于治疗实体肿瘤。
8.根据权利要求7所述的一种中药组合物的用途,其特征在于,所述肿瘤选自卵巢癌或肝癌。
9.根据权利要求7所述的一种中药组合物的用途,其特征在于,所述中药组合物具有至少以下一种功效:
a.通络止痛、行气、活血、消癥、止痛、燥湿、解毒;
b.逐瘀消癥、理气、活血、止痛、消肿、燥湿、解毒;
c.燥湿解毒、理气、化痰、活血、止痛、清热、解毒;
d.清热解毒、燥湿、理气、止痛、活血、散瘀、消癥。
10.根据权利要求7-9任意一项所述的一种中药组合物的用途,其特征在于,将所述中药组合物药粉放入透气外敷袋中,置于患处对应皮肤,所述药粉中心位置与病灶中心位置吻合,每日外敷10~12小时。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711167194.4A CN107714873A (zh) | 2017-11-21 | 2017-11-21 | 一种中药组合物及用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711167194.4A CN107714873A (zh) | 2017-11-21 | 2017-11-21 | 一种中药组合物及用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107714873A true CN107714873A (zh) | 2018-02-23 |
Family
ID=61217858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711167194.4A Pending CN107714873A (zh) | 2017-11-21 | 2017-11-21 | 一种中药组合物及用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107714873A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101322793A (zh) * | 2007-06-13 | 2008-12-17 | 张正中 | 癌症病变专治疗法 |
-
2017
- 2017-11-21 CN CN201711167194.4A patent/CN107714873A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101322793A (zh) * | 2007-06-13 | 2008-12-17 | 张正中 | 癌症病变专治疗法 |
Non-Patent Citations (4)
Title |
---|
庞香茹: "中西医结合治疗晚期恶性肿瘤", 《医药论坛杂志》 * |
李敏等: "癌痛灵贴膏外用治疗胰腺癌癌性疼痛的疗效观察", 《华西医学》 * |
王燕青等: "李达祥内病外治验案二则", 《中医外治杂志》 * |
陆益等: "香术止痛酊外治癌性疼痛的临床研究", 《时珍国医国药》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102755537B (zh) | 一种治疗腰腿痛的外用中成药及其用途 | |
CN104147577B (zh) | 一种用于促进骨痂生长治疗骨折的膏药 | |
CN103536858A (zh) | 一种治疗类风湿性关节炎的药物 | |
CN102872286B (zh) | 一种治疗腰间盘突出的中药组合物及其制备方法 | |
CN102512526B (zh) | 一种治疗早期骨伤及软组织损伤的药物 | |
CN107375845A (zh) | 祛风除湿通经活络的外用组合物及其使用方法 | |
CN104147516A (zh) | 一种治疗骨髓炎的中药组方 | |
CN106511905A (zh) | 一种用于治疗颈椎病的中药制剂及其制备方法 | |
CN107714873A (zh) | 一种中药组合物及用途 | |
CN104958520A (zh) | 一种治疗骨性关节炎的中药 | |
CN104825768A (zh) | 一种治疗淋巴结核的中药口服液及制备方法 | |
CN103381215A (zh) | 治疗胆囊炎及胆结石的中药组合物及其制备方法 | |
CN108379518A (zh) | 一种治疗卵巢癌的药物及其制备方法 | |
CN101757469B (zh) | 一种治疗风湿性关节炎的药物及其制备方法 | |
CN107753896A (zh) | 一种雪莲祛风膏及其制备方法 | |
CN103055271B (zh) | 一种用于治疗慢性胃炎的药物及制备方法 | |
CN106389657A (zh) | 一种治疗前列腺肥大的口服药及其生产方法 | |
CN105535869A (zh) | 一种可有效治疗噎嗝病的中药组合物及其制备方法 | |
CN102362932B (zh) | 一种治疗牛胸癀的外用药物 | |
CN104352773A (zh) | 治疗慢性支气管炎、支气管哮喘的中药制剂 | |
CN103638411B (zh) | 一种治疗淋巴结核的药物及其制备方法 | |
CN102526447B (zh) | 一种用于治疗低位直肠癌的外用药物的制作方法 | |
CN103784574A (zh) | 一种防治新生儿溶血症的内服中药 | |
CN108079255A (zh) | 一种祛风湿强筋骨活络油及其制备方法 | |
CN108143980A (zh) | 一种治疗晚期癌症疼痛的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180223 |